Innovations in biologics and gene therapies are creating new treatments for complex conditions, offering targeted and potentially curative options in areas like oncology and rare diseases. Aging population and rising chronic disease rates are driving... Explore Report »
Healthcare
Research Reports in Healthcare
Showing 10 results in Healthcare
Growing ethical concerns and legislative changes surrounding animal testing are a key driver. This technology provides a more accurate and human-relevant platform for assessing drug efficacy and toxicity, moving away from animal models that often fai... Explore Report »
The rising number of clinical trials for gene and cell therapies drives the U.S. plasmid DNA manufacturing market growth. These advanced treatments are heavily dependent on a large and consistent supply of high-quality plasmid DNA to support their de... Explore Report »
The rising number of people affected by chronic conditions, such as heart disease and diabetes, is a major growth factor. These conditions need continuous management and observation, which can be done effectively with monitoring devices. This helps r... Explore Report »
AI in genomics refers to the application of artificial intelligence technologies in the analysis, interpretation, and management of genomic data. The technology helps researchers and healthcare providers identify genetic variations, predict disease r... Explore Report »
CAR T-Cell Therapy is a cutting-edge form of immunotherapy which involves engineering a patient's T-cells to identify and destroy cancer cells. It is extensively applied in the treatment of blood cancers like lymphoma, leukemia, and multiple myeloma.... Explore Report »
Rising number of FDA-approved cell and gene therapies is accelerating clinical trial activity across academic and commercial research centers. Strong funding from NIH and private investors supports rapid expansion of early and late-stage trials in th... Explore Report »
Increasing global cancer burden is driving demand for cell line development by accelerating the need for stable and high-yield cell lines to support biologics and monoclonal antibody production. The rising global RD expenditures is fueling market gro... Explore Report »
Rise in infectious and chronic diseases is driving the use of molecular biology enzymes, reagents and kits to support molecular diagnostics, early disease detection and genetic analysis in clinical settings. Expanding biopharmaceutical RD and drug di... Explore Report »
Rising global incidence of non-small cell lung cancer (NSCLC) is accelerating the demand for molecular diagnostics, targeted therapies, and mutation-specific assays to enable early detection and personalized treatment planning. Growing clinical adopt... Explore Report »
Download Sample Report
Please fill out the form to receive sample pages of the report.
